Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Value Propositions
A New Molecular Cervical Cancer Test Will Aid Accurate Diagnosis
Value Propositions
,
Value Peer-spectives
September 2012, Vol 3, No 6
Quest Diagnostics, the leading provider of diagnostic testing, has introduced a new laboratory test that identifies molecular changes to cervical cells that may signal increased risk for cervical cancer.
Read Article
The Number of Cancer Survivors on the Rise in the United States
Value Propositions
,
Value Peer-spectives
September 2012, Vol 3, No 6
Read Article
Researchers Highlight Benefits of Exercise for Patients with Cancer
Value Propositions
,
Value Peer-spectives
July 2012, Vol 3, No 5
Several researchers at the University of Rochester Medical Center have been studying the effects of exercise on patients with cancer for some time now.
Read Article
First US Hospital Integrates Psychosocial Support Services in Its Cancer Center
Value Propositions
,
Value Peer-spectives
July 2012, Vol 3, No 5
Greenville Hospital System (GHS) has launched the Center for Integrative Oncology and Survivorship, which offers emotional services for cancer survivors developed by Cancer Support Community (CSC), an international provider of cancer-related social and emotional services.
Read Article
World’s First Pediatric Lymphoma Research Center Launched
Value Propositions
,
Value Peer-spectives
July 2012, Vol 3, No 5
Texas Children’s Cancer Center has opened the first center dedicated entirely to the research, care, and treatment of children with lymphoma. The Fayez Sarofim Lymphoma Center at Texas Children’s Cancer Center was made possible by a gift of $10 million to Texas Children’s Hospital.
Read Article
New Biomarker a Promising Development in Ewing’s Sarcoma
Value Propositions
,
Value Peer-spectives
July 2012, Vol 3, No 5
A team of researchers from the University of Colorado led by Tyler Robin, PhD, Department of OB/GYN, Denver Anschutz Medical Campus, has discovered a new biomarker in Ewing’s sarcoma that explains the lack of disease response to current chemotherapy in some patients with this cancer, who until now have had a very poor prognosis.
Read Article
Precision Diagnostics Currently the True Value of Personalized Medicine
Value Propositions
,
Value Peer-spectives
July 2012, Vol 3, No 5
>According to Genome Health Solutions cofounder Mark S. Boguski, MD, PhD, FCAP, Harvard Medical School’s Center for Biomedical Informatics and Beth Israel Deaconess Medical Center, at this point in time, the promise of genomics lies “not so much in therapeutics or disease prevention, but in precision diagnostics that will really enable personalized medicine.
Read Article
Will Merger of 2 Major Diagnostic Centers Up Access to Molecular Imaging?
Value Propositions
,
Value Peer-spectives
June 2012, Vol 3, No 4
Two of the largest diagnostic imaging centers in the country—Insight Imaging in California and Centers for Diagnostic Imaging (CDI) in Minneapolis—have announced that they are merging forces.
Read Article
Radium-223 Offers New Hope for Patients with Bone Metastases
Value Propositions
,
Value Peer-spectives
June 2012, Vol 3, No 4
At the 2012 annual meeting of the Society of Nuclear Medicine, researchers presented new results for the radioisotope therapy radium-223 chloride, suggesting that these results represent a new treatment protocol for patients with advanced prostate cancer that has spread to the bone.
Read Article
Understanding Genes Is Crucial to Predicting Response to Breast Cancer Therapy
Value Propositions
,
Value Peer-spectives
June 2012, Vol 3, No 4
A study funded by the National Cancer Institute, the National Institutes of Health, a Theodore N. Law Endowment for Scientific Achievement, and a Dodie P. Hawn Fellowship in Cancer Genetics Research surprisingly showed that the presence of normal
p53
, a tumor suppressor gene and not the mutated gene, was making chemotherapy with doxorubicin less effective in breast cancer; it is the mutated gene that actually enhances the benefit of the drug and not the reverse.
Read Article
Page 7 of 11
2
3
4
5
6
7
8
9
10
11
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma